Tue, October 31, 2023
Mon, October 30, 2023
Fri, October 27, 2023
Thu, October 26, 2023
Wed, October 25, 2023

Ami Fadia Maintained (BPMC) at Strong Buy with Increased Target to $74 on, Oct 27th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-74-on-oct-27th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ami Fadia of Needham, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $66 to $74 on, Oct 27th, 2023.

Ami has made no other calls on BPMC in the last 4 months.



There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 0 agree with Ami's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Ami


  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $114 on, Monday, August 7th, 2023
  • Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $83 on, Thursday, August 3rd, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $85 on, Thursday, August 3rd, 2023
  • Derek Archila of "Wells Fargo" Upgraded from Hold to Buy and Increased Target to $83 on, Monday, July 31st, 2023

Publication Contributing Sources